Published online Jun 21, 2021. doi: 10.3748/wjg.v27.i23.3303
Peer-review started: January 28, 2021
First decision: February 24, 2021
Revised: March 10, 2021
Accepted: May 24, 2021
Article in press: May 24, 2021
Published online: June 21, 2021
Processing time: 140 Days and 5.9 Hours
Core Tip: Gastrointestinal signs and symptoms seem to be more common in paediatric coronavirus disease 2019 (COVID-19) compared to adults. Manifestations are generally self-limited, and may only require supportive treatment. In a minority of children, gastrointestinal involvement may precede severe forms such as the multisystem inflammatory syndrome. Conversely to what is expected, the COVID-19 impact on paediatric patients with chronic gastrointestinal diseases is limited, with no need for therapeutic regimen changes. However, the severe acute respiratory syndrome coronavirus 2 pandemic determined multiple variations in routine practice. The use of telemedicine and telehealth can be a solution in order to continue to provide regular follow-up to chronic patients, avoiding the risk of viral transmission.
